|
Overview
| Sessions Include |
- Multifunctional
Nanoparticles: Unique Challenges
-
Acceptance Barrier Issues
-
Recognition and Therapeutic Delivery
-
Targeting Approaches
-
Nanoparticle Vaccine Delivery
|
| Nanotech Opportunities for the Pharma Industry |
- Combining Drugs and Imaging Agents
- Increasing Oral Absorption with Nanoemulsions
- Reducing Toxicity
- Addressing Unmet Medical Needs
- Improving Success Rates
|
|
Scientific
Advisory Board
|
- Carol A. Dahl, Ph.D., Bill & Melinda Gates Foundation
- Mauro Ferrari, Ph.D., University of Texas Health Science Center, M.D. Anderson Cancer Center,
and Rice University
- Scott E. McNeil, Ph.D., NCI-Frederick
- Celeste Null, MSE, CQA, Intel Corp.
- James L. Tatum, Ph.D., National Cancer Institute
- Stephen McCormack, Ph.D., NeuroSystec Corp.
- Piotr Grodzinski, Ph.D., National Cancer Institute
|
|
|
